Australia Diagnostic Imaging Market 2026 – 2035

It is estimated that the market size of the Australia diagnostic imaging will be USD 1.02 billion in 2025 and will rise to a range of USD 1.86 billion in 2035 (compared to USD 1.08 billion in 2026), at CAGR of 6.15% between 2026 and 2035. Market growth is caused by the rising rate of chronic illnesses, the aging population demographics, new technological changes in the medical imaging field, the increasing need to identify diseases early, the positive government healthcare programs, the expansion of the diagnostic infrastructure, and the increase in healthcare spending.

Market Highlight

• The Australian market is projected to have one of the largest shares of diagnostic imaging equipment in the Asia-Pacific region with a share of about 1.8% in 2025.

• By mode the ultrasound systems segment took about 39% of the market share in 2025 due to the portability, safety and versatility of use.

• By modality, computed tomography segment is increasing its CAGR with the highest rate of 7.97% between 2026 and 2035 with the rise of advanced multidetector systems and integration of AI.

• Application Oncology segment is expected to have the largest market share of 25% in 2025 and the cardiology segment will have a CAGR of 7.81% in the expected yearly projection between 2026 and 2035.

• By end user, hospitals took 70% market share in 2025, and diagnostic imaging centers are increasing at the highest rate of 7.68% CAGR.

• The diagnostic imaging services sector industry earned a worthy revenue of AUD 5.8 billion in 2025 and it employs thousands of healthcare professionals including radiologists, imaging technologists, and support personnel in the sector.

Significant Growth Factors

The Australia Diagnostic Imaging Market Trends present significant growth opportunities due to several factors:

Escalating Chronic Disease Burden and Rapidly Aging Population:

The rising level of the occurrence of chronic disease and the growing age of the Australian population are the leading factors in the diagnostic imaging market, where millions of Australians need high sophistication imaging medicines to accurately diagnose, monitor and plan their treatment. The Australian Institute of Health and Welfare reported that in the year 2024, chronic conditions have contributed to 64% of the overall disease burden, with cancer, cardiovascular diseases, musculoskeletal conditions, mental health disorders, and neurological conditions being the five most significant disease groups in terms of their impact on population health. In the year 2024, CVD had almost 12% of the total disease burden, with nearly 685,000 years of life lost to CVD in Australians which is equal to 25.5 years per 1,000 people. Cancer is the most frequent cause of premature mortality in Australia, and it is one-third of the fatal burden in 2023, and diagnostic imaging is imperative in diagnosing and staging and treatment monitoring in all oncology applications.

The aging population increases the demand on imaging as the age of persons over 65 years old has already reached 17.1% in 2025 with an expected increase in the number of these people from 4.31 million in 2021 to 6.66 million in 2041. The median age has risen since 1991 by 32.4 years to 38.3 years in 2025, which means that Australia is shifting to the older type of population structure with far-reaching effects on healthcare needs and requirements of diagnostic imaging. The burden of illness among the indigenous Australians is estimated at almost 240,000 healthy life-years each year, which is why the targeted subsidies of imaging services are offered in underserved populations to reduce healthcare disparities. The Australian Burden of Disease Study reported that coronary heart disease was the most prevalent single cause of burden in males as well as the sixth most prevalent in females in 2024, and as such diagnosis and management of cardiovascular disease relies on diagnostic imaging.

The Commonwealth government has also invested a significant amount of funds in aged care services in 2021-22 amounting to AUD 24.8 billion, which shows its dedication to investing in supporting an aging population that needs regular diagnostic imaging to manage degenerative diseases, comorbidities, and age-related conditions. Australia has a life expectancy of 81.1 years and 85.1 years respectively, placing it on the list of the longest populations globally, which creates a persistent supply of diagnostic imaging services to the elderly population who have increased cancer, cardiovascular disease, neurological and musculoskeletal rates among other issues to monitor regularly.

• Technological Innovation and AI Integration in Medical Imaging:

Diagnostic imaging technologies are fast becoming more innovative, and this increased accuracy, efficiency, and safety of diagnostic procedures are applied across various modalities. The combination of artificial intelligence, 3D imaging, PET-CT hybrid solutions, low-dose radiation regimes, and cloud-based imaging has transformed the possibilities of diagnostics and has increased the quality of images, decreased scan time, patient comfort, and accuracy of diagnoses. Harrison.ai raised USD 112 million in 2025 to perfect multi-modality algorithms currently in use by half of Australian radiologists and serving 6 million patients each year, showing the incredible market penetration of AI-driven diagnostic solutions. There are vendors that sell AI triage engines like GE HealthCare CareIntellect to speed up delivery of reports when using oncology complex pathways to overcome workforce shortages and enhance diagnostic accuracy and clinical workflow efficiency. Australian X-ray innovator Micro-X won up to USD 16.4 million from the US Advanced Research Projects Agency for Health in February 2025, to develop a full-body mobile CT scanner, a breakthrough innovation in portable diagnostic imaging that will solve accessibility issues in rural and remote locations.

In March 2025, Body Vision medical declared that they had been given the green light on their LungVision advanced imaging technology by the Therapeutic Goods Administration in Australia, indicating regulatory acceptance of AI-powered intraoperative imaging technology to improve the accuracy of diagnosis in surgical operations. GE HealthCare is an example of a company that partners with NVIDIA to co-engineer autonomous X-ray positioning and ultrasound scanning technologies, overcoming staffing challenges and improving throughput without affecting the quality of the diagnostic. Siemens presents Ciartic Move, a self-driving C-arm, which reduces the time required for intraoperative imaging by 50% to enhance the efficiency of the surgical workflow and patient outcomes.

The BlueSeal helium-light MRI by Philips also saves 40 Mwh of energy per year per system which is a concern for sustainability, as well as saves on costs incurred by healthcare institutions in terms of operation. The use of digital technologies such as teleradiology and cloud-based imaging systems improves data exchange, makes diagnostics available remotely, makes the work of patients in geographically remote territories more accessible, and simplifies the interaction of healthcare professionals working in geographically isolated places. The number of CT scanners, MRI and PET scanners per million population stands at 94 in Australia as compared to 51 in the OECD, which implies that the state has a significant installed base and infrastructure to support the use of the diagnostic imaging.

What are the Major Advances Changing the Australia Diagnostic Imaging Market Today

• Artificial Intelligence and Machine Learning Integration:

The integration of Artificial Intelligence and machine learning technologies is the most radical change in the field of diagnostic imaging that has changed the way images and data are obtained, interpreted, and workflow processes, and determines the level of diagnostics in various imaging modalities.

The multi-modality algorithms by Harrison.ai are applied by half of the Australian radiologists, with 6 million patients every year and show a wide usage of AI-based diagnostic tools to promote better clinical decision-making, decrease interpretation time, and increase diagnostic accuracy. AI-based imaging can process images automatically and identify anomalies such as tumor, fracture, and cardiovascular anomalies with similar or better accuracy than human radiologic specialists, and lower the time to interpretations and handle workforce shortages in healthcare provision. Machine learning algorithms can process large datasets of medical images, detecting hidden patterns and anomalies that a human observer might fail to notice and provide earlier detection of the disease and better patient outcomes due to timely interventions. Vendors implement AI triage engines that prioritize urgent cases, simplify workflow in large radiology hospitals, decrease report turnaround, and deliver critical results to urgent clinical decisions.

Computer-aided detection systems would help radiologists detect suspicious lesions in mammography, chest x-rays and CT scans which would increase cancer detection rates, decrease false negatives and aid screening programs that are targeted at the high-risk groups. Image reconstruction technologies improve the quality of images, lower radiation dose, and shorten scanning time using deep learning algorithms, which improves patient safety and comfort and does not compromise the quality of diagnosis. Integrated natural language processing technologies allow the creation of reports automatically, obtaining important findings in the image and creating organized reports, with fewer administrative tasks and better documentation of radiologists. Remote access to state-of-the-art diagnostic tools via cloud-based AI systems leads to healthcare facilities in rural and regional locations to enjoy the advantages of the latest technologies without physical on-site expertise to compensate geographical differences in healthcare availability. Predictive analytics implemented with the help of AI algorithms predict patient outcomes, disease progression, and treatment responses according to the data provided by the imaging service and electronic health records so that the approach to personal medicine could be developed, and the treatment planning could be enhanced.

• Portable and Point-of-Care Imaging Solutions:

The market is expected to face intense competition because numerous companies are launching their portable and point-of-care imaging systems or devices to enhance the accessibility of healthcare systems in emergency departments, intensive care units, operating rooms, rural health care facilities, and home care environments where conventional fixed imaging technologies are ineffective or nonexistent.

The portable imaging innovation by Micro-X of a full-body mobile CT scanner with USD 16.4 million funding by ARPA-H is an example of micro innovation in the field of portable imaging involving the accessibility issue in remote locations, disaster recovery, and emergency medical services where rapid diagnostic solutions are required. Portability, ease of use and real-time imaging Handheld ultrasound systems can also be used to provide point-of-care diagnostics in primary care hospitals, emergency departments, and rural health care facilities where access to conventional ultrasound systems is restricted. Mobile imaging units with X-ray, ultrasound, and mammography services go to the rural and remote communities, where people experience geographical impediments to access healthcare, enhancing early disease diagnosis and minimizing health inequities. The use of wireless and battery-powered imaging devices has eliminated the need to have infrastructure in place, providing an opportunity to deploy these devices in field hospitals, aged care, and home care settings, and extending the scope of diagnostic imaging services to non-traditional healthcare facilities.

Small MRI systems in development have a smaller size and lower cost of installation and less complex operation in comparison to the size of a conventional MRI scanner, potentially making MRI widely available in smaller healthcare facilities and regional hospitals that do not have this diagnostic tool at present. Point-of-care imaging saves the need to transfer patients, shortens patient clinical decision time, and enhances patient outcomes through point-to-treatment imaging, especially in emergency medicine, critical care, and perioperative imaging. The combination of telemedicine with portable imaging equipment allows consultation with radiologists and specialists even at distant locations, provides the ability to interpret the image by an expert with the help of telemedicine, and facilitates the making of clinical decisions in areas where they are underserved.

The introduction of the Mobile PET-CT service by Mercy Radiology and Mobile Health Group in May 2024 expands access to advanced imaging across the community with the introduction of the new service where highly advanced diagnostic services are brought to patients in the regional setting and increased access to populations with mobility issues or transportation problems.

• Hybrid Imaging Systems and Multimodal Approaches:

Hybrid imaging systems and multimodal solutions The development of hybrid imaging systems into single platforms that integrate multiple imaging modalities offers a disruptive pattern that yields complementary data that improves the accuracy of diagnosis, treatment planning, and disease monitoring in a variety of clinical applications. In oncology fields, PET-CT systems have been used to allow localization of tumors, evaluate treatment response, and detect metastatic disease by combining anatomical information provided by computed tomography with metabolic information provided by positron emission tomography.

The proliferating mobile PET-CT services in Australia enhance the accessibility of advanced imaging to cancer patients in the rural regions, and they do not have to travel long distances to the city to find the services, and each has equal access to the state-of-the-art imaging technologies. PET-MRI systems can provide combined metabolic data and soft tissue data with no radiation exposure (CT), especially in pediatric cancer imaging, neurology, and cardiovascular imaging, where radiation dose is of utmost importance. SPECT-CT (single-photon emission computed tomography with CT) offers accurate anatomical localization in the uptake of radiotracers in studies of nuclear medicine to enhance the diagnostic accuracy of cardiovascular disease, bone metastases, and neuroendocrine tumors. Multimodal imaging techniques are based on the combination of two or more types of imaging data, which allow a more complete characterization of the disease, enhance the accuracy of the staging, and allow the planning of specific treatment based on the characteristics of each individual patient. Hybrid systems help eliminate several different imaging studies, enhance patient comfort, decrease healthcare expenses, and simplify clinical processes through offering full diagnostic data during a single examination session.

The latest visualization software allows us to fuse images made in other modalities obtained at a different time, allowing us to track the disease progression, evaluate the treatment effect, and identify the disease relapse. Artificial intelligence combined with the hybrid imaging systems is beneficial in improving the interpretation of the image and the automation of lesion detection and quantification and decision support tools in oncology treatment planning and response evaluation.

• Low-Dose Imaging Protocols and Radiation Safety Enhancements:

Low dose imaging protocols development and implementation is a crucial development, especially in cases of pediatric imaging, patients needing frequent imaging, or screening programs where the patient has no symptoms, and radiation exposure needs to be minimized.

The iterative reconstruction algorithms in CT imaging allow to lower the radiation dose by a significant margin without losing the quality of the images and allow diagnostic examinations with radiation doses up to 90% less than those required by conventional protocols, which makes it much safer for patients without reducing the diagnostic accuracy. Since radiation dose depends on patient size and area of interest, automatic exposure control ensures that the minimum radiation dose is used to obtain diagnostic quality images, especially in patients who are more sensitive to radiation such as pediatric patients. Digital radiography systems are used to substitute the X-rays on film, providing a higher quality of images, with significantly reduced radiation levels, instant access to images and no use of chemical processing, making workflow more efficient and more environmentally friendly. Dose tracking and management systems follow cumulative radiation exposure in a series of imaging tests and as a result, the healthcare provider can optimize imaging protocols, justify the appropriateness of imaging, and reduce unwarranted radiation exposure over the course of patient lifetimes. National dose reference levels and diagnostic reference levels provide standards by which radiation exposure during diagnostic imaging processes is established to facilitate quality improvement programs and to maintain the radiation doses as low as possible without compromising quality.

The BlueSeal MRI technology created by Philips also eliminates the helium boil off thereby minimizing the effect on the environment and operation cost as well as promoting the sustainable healthcare practices in the medical imaging sector. Other imaging techniques such as ultrasound and MRI have become radiation free, which is more commonly used in the diagnosis of childhood diseases, obstetric imaging and disease surveillance over time where, in such cases, recurrent imaging studies are needed. Education of patients and shared decision making models ensure that the patients are aware of the risks and benefits of radiation and therefore make informed consent on the imaging procedures and encourage the proper use of diagnostic imaging services.

Category Wise Insights

By Modality

Why Ultrasound Systems Lead the Market?

The greatest segment in 2025 will be ultrasound systems, which will constitute about 39% of the total market share. This supremacy indicates the versatility of ultrasound, its safety record, its portability, and its wide range of clinical uses. Ultrasound prevails because it has a radiation-free image, the ability of real-time visualization, portability to provide point-of-care diagnosis, the relatively low cost of the equipment compared to CT and MRI, and the broad scope of use in obstetrics, cardiology, abdominal imaging, musculoskeletal use, and vascular imaging. Ultrasound can be the imaging modality of choice in pediatric patients, pregnant women, and patients with chronic disease monitoring because it has no ionizing radiation, and the issue of radiation exposure to the patient by X-ray and CT is not a problem with ultrasound.

Portable and handheld ultrasound devices have increased the availability of imaging in facilities outside the traditional radiology department and have been used in point-of-care diagnosis in emergency departments, intensive care units, general practice clinics and rural healthcare facilities where access to the high-image systems is not widespread. Technological innovations such as 3D, 4D ultrasound imaging, contrast-enhanced ultrasound, elastography as a measurement of tissue stiffness, and fusion imaging ultrasound-CT or ultrasound-MRI have increased clinical uses and better diagnostic outcomes. In November 2024, Philips collaborated with Edith Cowan University to deliver clinical-ultrasound training to people in the Asia-Pacific region, which is a sign of the industry's willingness to invest in the workforce and advance ultrasound use in various clinical practices.

Computed tomography is the one that is growing fastest with the predicted CAGR of 7.97% between 2026 and 2035 because of the technological developments in multidetector CT systems, dual-energy CT, spectral imaging, and artificial intelligence integration to enhance image quality and diagnostic accuracy, as well as increasing clinical uses in addition to the conventional diagnostic imaging. High technology CT systems have a shorter scan time, higher spatial resolution, a lower amount of radiation due to iterative reconstruction models, and a better ability to characterize soft tissues making more accurate diagnoses in oncology, cardiovascular, neurological and trauma cases. The invention of the full-body mobile CT scanner by Micro-X can be considered as a revelation concerning the issue of accessibility in emergency medicine, rural healthcare, and disaster response situations, where speed of scanning diagnostic images is of utmost importance in order to triage patients and plan a treatment.

By Application

Why Oncology Dominates Diagnostic Imaging Applications?

The greatest fragment is oncology applications, which will command an estimated 25% of market share in 2025. This leadership is in line with the inherent nature of diagnostic imaging as a component of cancer detection, staging, treatment planning, response assessment, and surveillance, with imaging modalities such as CT, PET-CT, MRI, mammography, and ultrasound being important tools in the cancer care continuum. In Australia, cancer is the major cause of death in the working-age, with one-third of the mortality burden in 2023, and diagnostic imaging has a significant role in early-onset cancer diagnosis to enhance survival rates and therapy outcomes.

The multimodal imaging methods that incorporate both anatomical and functional data allow a multifaceted characterization of the cancer, precise staging that identifies the treatment strategies, evaluation of the distribution of the metastatic disease, evaluation of the response to the treatment that identifies the need to change treatment, and surveillance to identify a recurrence that can ensure a timely response. Breast cancer detection screening programs involving mammography screening prove the significance of imaging in cancer prevention, and the rate of participation directly influences the outcome of early detection and reduction of mortality. PET-CT has become a standard of care to stage and restage a variety of different malignancies such as lung cancer, lymphoma, melanoma, and colorectal cancer and to give metabolic data that supplements anatomical data and enhances the diagnostic accuracy. Intelligent imaging analysis can improve cancer detection, decrease false negative rates with screening programs, scale tumors automatically to support response evaluation, and precision oncology using radiomics to extract measurable characteristics of medical images that forecast prognosis and treatment outcomes.

The quickest is the cardiology sector with the expected CAGR of 7.81% between 2026 and 2035 due to the extensive burden of cardiovascular disease in Australia, with CVD as 12% of the total disease burden in 2024, and the expanding focus on preventive cardiology where the need to assess cardiovascular risk is requiring imaging of the heart. CVD has important morbidity and mortality, and in 2024, it is estimated that Australians will have lost 685,000 years of healthy life because of CVD, thus generating a lasting need for diagnostic imaging to facilitate early disease detection, risk identification, treatment planning, and monitoring of cardiovascular diseases. The development of advanced imaging modalities has facilitated the process of noninvasive evaluation of coronary artery disease, myocardial viability, cardiac function, and congenital heart disease, thereby eliminating the use of invasive methods of diagnostic procedures and offering comprehensive cardiovascular evaluation to support clinical judgment.

By End User

Why Hospitals Dominate the Market?

The biggest segment will be hospitals, which will take up the advisable 70% market share in 2025. Such preeminence is indicative of the density of high-end imaging machines in hospitals, the full scope of diagnostic services needed in inpatient and emergency care, interdepartmental clinical integration, and access to specialized radiologists and imaging technologists that augment intricate diagnostic services. Hospitals have large imaging machinery such as various modalities and offer 24/7 diagnostic services to emergency departments, intensive care units, operating rooms, and inpatient wards that need urgent imaging of acute patients, trauma, and surgical planning.

The teaching hospitals and tertiary care centers contain the latest imaging tools, such as 3T MRI machines, PET-CT machines, and interventional radiology suites among others that are referral centres of complex cases where specialized imaging skills and advanced diagnostic abilities are required. Emergency departments produce large volumes of imaging, and CT imaging is necessary in trauma care, stroke, acute abdominal pain, and pulmonary embolism diagnosis, which promotes high implementation of equipment and rationalization of capital investments in high-technology imaging services. Imaging services should be integrated with the hospital information system, electronic health record, and picture archiving and communication system to provide continuous clinical processes, real-time access to images for treating physicians, and continuity of care through longitudinal access to imaging studies.

The Diagnostic imaging center has been the most rapidly growing category, with a projected CAGR of 7.68% between 2026 and 2035 due to the growing amount of outpatient imaging, the emergence of specialized imaging centers with dedicated imaging offering quality services, shorter waiting time than hospital-based imaging, convenient locations in suburban areas, and affordable prices that attract patients with private healthcare insurance and other self-pay patients who need elective imaging.

The diagnostic imaging center segment is dominated by large corporate chains such as Sonic Healthcare, I-MED Radiology Network, Capitol Health, and Integral Diagnostics, which run chains of facilities in metropolitan and regional regions and have the economies of scale of equipment procurement and operation and of quality imaging services that are standardized. Specialized imaging centers specialize in outpatient diagnostic imaging, which includes women's imaging, musculoskeletal imaging, and cardiac imaging, and streamlined operations, convenient scheduling, and patient-centered service provision are some of the differences between dedicated imaging centers and facilities operating in the hospital setting. The Medicare financing of outpatient services related to diagnostic imaging allows patients to receive imaging services at centers with bulk-billing arrangements that minimize out-of-pocket expenses, which will increase volume especially in an imaging center with routine imaging services such as X-rays, ultrasound, and CT studies.

Report Scope

Australia Diagnostic Imaging Market

How Significant is the Industry's Economic Contribution?

Australia diagnostic imaging business is a major contributor to healthcare services, and the diagnostic imaging services segment is expected to make AUD 5.8 billion in revenue in 2025, increasing by 5.3% over the last year. The market has shown consistent growth of 5.8% CAGR in 2019-24 also indicating that despite the economic cycles and the COVID-19 pandemic, the market has been very resilient through the provision of some crucial diagnostic services that keep the population healthy. Australia has a healthcare expenditure of USD 7,469 per capita which is more than the OECD average of USD 5,967, a 10.3% of GDP and indicates that the country has made significant investments in healthcare infrastructure such as diagnostic imaging equipment, facilities and services. It has a workforce of thousands of skilled healthcare professionals such as radiologists, imaging technologists, radiographers, nuclear medicine technologists, medical physicists, and support personnel, which offers high-skilled employees and has led to the development of the workforce in the field of healthcare technology.

The proportion of CT scanners, MRI units and PET scanners per million population in Australia is 94, compared to 51 in the OECD, which means that there are high levels of capital investments in diagnostic imaging infrastructures and high quality equipment that is able to support the diagnostic services. Diagnostic imaging industry assists in medical research and trials, and imaging endpoints are crucial in the field of assessing the effects of treatment in drug development, developing medical science, and luring international research investigations to Australian organizations.

What is the Industry's Infrastructure and Technology Investment?

The experience of the diagnostic imaging industry is one of high infrastructure spending as the largest healthcare providers, hospital systems and corporate imaging networks have kept upgrading equipment and facilities and adopting new technologies that have improved diagnostic capabilities and services to patients. Each year, hundreds of millions of dollars are spent by the public hospitals and the private health care providers in medical imaging equipment acquisitions, facility development, technology renovations, and information system developments as a part of ongoing enhancement of diagnostic services to the patients and international standards of healthcare delivery. The Medicare government funding covers the use of diagnostic imaging with billions of dollars annually being used on imaging benefits that allow patients to access the services they need to detect their diseases in their early stages and assist in making evidence-based clinical decisions in all fields of therapy.

The Diagnostic Imaging Accreditation Scheme guarantees the quality standards, whereby the equipment must be maintained on a regular basis, quality control tests must be performed, staff members must be credentialed, and the facilities must meet the technical standards to sustain continuous quality enhancement and to ensure the best international practice in the provision of diagnostic imaging services. The infrastructure of telemedicine and teleradiology makes it possible to report remotely, consult specialists, and provide after hours care, enhance the efficiency of the services offered, improve the delivery of health services to the rural and regional areas; and access subspecialty expertise irrespective of where the geographical location is. Technological innovation is driven by research and development efforts of the equipment manufacturers such as Siemens Healthineers, GE HealthCare, Philips, Canon, and FUJIFILM and collaborative efforts between the industry and the academic institutions have developed imaging science, novel application development, and translation of the research findings into clinical practice.

Top Players in the Market

• Siemens Healthineers AG

• GE HealthCare

• Koninklijke Philips N.V.

• Canon Medical Systems Corporation

• FUJIFILM Holdings Corporation

• Sonic Healthcare Limited

• I-MED Radiology Network

• Capitol Health Limited

• Integral Diagnostics Limited

• Harrison.ai

• Others

Key Developments

The market has undergone significant developments as industry participants seek to expand capabilities and enhance service offerings.

• In March 2025: Body Vision Medical announced that its LungVision imaging system received approval in Australia, which is the Therapeutic Goods Administration. With AI-enhanced imaging, the intraoperative imaging system enables surgeons to navigate through lung procedures more precisely and achieve better results with thoracic surgery patients.

• In February 2025: Micro-X received up to USD 16.4 million from the U.S. Advanced Research Projects Agency on Health. The investment will assist in the construction of the first full-body mobile CT scanner in the world, which has the potential to revolutionize the field of portable imaging in the areas of emergency care, rural health, and disaster management.

These strategic activities have allowed companies to strengthen market positions, expand technological capabilities, enhance workforce competencies, and capitalize on growth opportunities within the expanding market.

The Australia Diagnostic Imaging Market is segmented as follows:

By Modality

• X-Ray Systems

o   Digital Radiography

o   Analog Radiography

• Computed Tomography

o   High-Slice CT

o   Mid-Slice CT

o   Low-Slice CT

• Magnetic Resonance Imaging

o   Closed MRI Systems

o   Open MRI Systems

• Ultrasound Systems

o   2D Ultrasound

o   3D and 4D Ultrasound

o   Doppler Ultrasound

• Nuclear Imaging

o   PET Scanners

o   SPECT Scanners

o   Hybrid Imaging

• Fluoroscopy

• Mammography

o   Digital Mammography

o   Analog Mammography

By Application

• Oncology

• Cardiology

• Neurology

• Orthopedics

• Gastroenterology

• Gynecology

• Other Applications

By End User

• Hospitals

• Diagnostic Imaging Centers

• Other End Users